Arterial embolism
Arterial embolism refers to a blood clot or foreign matter that enters a blood vessel and becomes an embolus. As blood flow stops in a peripheral artery or visceral artery of similar smaller caliber, it causes blood flow obstruction.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
More common in men over 45 years old -
Related symptoms:
Intermittent claudication lower back pain buttocks pain iliac fossa pain calf muscle pain and tenderness -
Concurrent disease:
Related Drugs
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. 4. Blood in a state of high viscosity, high coagulation, and prethrombotic state. 5. Sudden deafness. 6. Pulmonary embolism.
Manufacturer:
Tianjin Biochemical Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. 4. Blood in a state of high viscosity, high coagulation, and prethrombotic state. 5. Sudden deafness. 6. Pulmonary embolism.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrence of cerebral infarction; 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrence of myocardial infarction; 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease; 4. Blood in a hyperviscosity state, hypercoagulable state, and pre-thrombotic state; 5. Sudden deafness; 8. Pulmonary embolism.
Manufacturer:
Henan Xintai Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrence of cerebral infarction; 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrence of myocardial infarction; 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease; 4. Blood in a hyperviscosity state, hypercoagulable state, and pre-thrombotic state; 5. Sudden deafness; 6. Pulmonary embolism.
Manufacturer:
Ji Lin Jin Sheng Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrence of cerebral infarction; 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrence of myocardial infarction; 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease; 4. Blood in a hyperviscosity state, hypercoagulable state, and pre-thrombotic state; 5. Sudden deafness; 6. Pulmonary embolism.
Manufacturer:
Guangzhou Invin Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrence of cerebral infarction; 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrence of myocardial infarction; 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease; 4. Blood in a hyperviscosity state, hypercoagulable state, and pre-thrombotic state; 5. Sudden deafness; 6. Pulmonary embolism.
Manufacturer:
Guangzhou Invin Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. 4. Blood in a state of high viscosity, high coagulation, and prethrombotic state. 5. Sudden deafness. 6. Pulmonary embolism.
Manufacturer:
NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.
Defibrase for injection
Indication: 1. Acute cerebral infarction, including cerebral thrombosis, cerebral embolism, transient ischemic attack (TIA), and prevention of recurrent cerebral infarction. 2. Myocardial infarction, unstable angina pectoris, and prevention of recurrent myocardial infarction. 3. Vascular diseases of the limbs, including femoral artery embolism, thromboangiitis obliterans, and Raynaud's disease. 4. Blood in a state of high viscosity, high coagulation, and prethrombotic state. 5. Sudden deafness. 6. Pulmonary embolism.
Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Shandong Fenghuang Pharmaceutical Co., Ltd.
Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; 4. Ocular blood circulation disorders such as diabetic retinal artery embolism.
Related Ingredients